Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score

Abstract

PCNA score has potential value as a prognostic indicator in breast cancer. This method of assessing the proliferating pool offers advantages over other assays in terms of relative simplicity of the method, applicability to paraffin-embedded fixed tissue, and low cost.